BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 27545813)

  • 1. Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.
    Rother S; Samsonov SA; Hofmann T; Blaszkiewicz J; Köhling S; Moeller S; Schnabelrauch M; Rademann J; Kalkhof S; von Bergen M; Pisabarro MT; Scharnweber D; Hintze V
    Acta Biomater; 2016 Nov; 45():143-154. PubMed ID: 27545813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfated Hyaluronan Alters the Interaction Profile of TIMP-3 with the Endocytic Receptor LRP-1 Clusters II and IV and Increases the Extracellular TIMP-3 Level of Human Bone Marrow Stromal Cells.
    Rother S; Samsonov SA; Hempel U; Vogel S; Moeller S; Blaszkiewicz J; Köhling S; Schnabelrauch M; Rademann J; Pisabarro MT; Hintze V; Scharnweber D
    Biomacromolecules; 2016 Oct; 17(10):3252-3261. PubMed ID: 27610455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated Hyaluronan Alters Endothelial Cell Activation in Vitro by Controlling the Biological Activity of the Angiogenic Factors Vascular Endothelial Growth Factor-A and Tissue Inhibitor of Metalloproteinase-3.
    Rother S; Samsonov SA; Moeller S; Schnabelrauch M; Rademann J; Blaszkiewicz J; Köhling S; Waltenberger J; Pisabarro MT; Scharnweber D; Hintze V
    ACS Appl Mater Interfaces; 2017 Mar; 9(11):9539-9550. PubMed ID: 28248081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan/collagen hydrogels containing sulfated hyaluronan improve wound healing by sustained release of heparin-binding EGF-like growth factor.
    Thönes S; Rother S; Wippold T; Blaszkiewicz J; Balamurugan K; Moeller S; Ruiz-Gómez G; Schnabelrauch M; Scharnweber D; Saalbach A; Rademann J; Pisabarro MT; Hintze V; Anderegg U
    Acta Biomater; 2019 Mar; 86():135-147. PubMed ID: 30660005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone.
    Salbach-Hirsch J; Samsonov SA; Hintze V; Hofbauer C; Picke AK; Rauner M; Gehrcke JP; Moeller S; Schnabelrauch M; Scharnweber D; Pisabarro MT; Hofbauer LC
    Biomaterials; 2015 Oct; 67():335-45. PubMed ID: 26232882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
    Wang L; Almqvist KF; Veys EM; Verbruggen G
    Osteoarthritis Cartilage; 2002 Mar; 10(3):188-98. PubMed ID: 11869079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycans influence enzyme activity of MMP2 and MMP2/TIMP3 complex formation - Insights at cellular and molecular level.
    Ruiz-Gómez G; Vogel S; Möller S; Pisabarro MT; Hempel U
    Sci Rep; 2019 Mar; 9(1):4905. PubMed ID: 30894640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycan derivatives: promising candidates for the design of functional biomaterials.
    Scharnweber D; Hübner L; Rother S; Hempel U; Anderegg U; Samsonov SA; Pisabarro MT; Hofbauer L; Schnabelrauch M; Franz S; Simon J; Hintze V
    J Mater Sci Mater Med; 2015 Sep; 26(9):232. PubMed ID: 26358319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix.
    Yu WH; Yu S; Meng Q; Brew K; Woessner JF
    J Biol Chem; 2000 Oct; 275(40):31226-32. PubMed ID: 10900194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan/Collagen Hydrogels with Sulfated Glycosaminoglycans Maintain VEGF
    Rother S; Ruiz-Gómez G; Balamurugan K; Koehler L; Fiebig KM; Galiazzo VD; Hempel U; Moeller S; Schnabelrauch M; Waltenberger J; Pisabarro MT; Scharnweber D; Hintze V
    ACS Appl Bio Mater; 2021 Jan; 4(1):494-506. PubMed ID: 35014301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rd1 mouse retina shows imbalance in cellular distribution and levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and sulfated glycosaminoglycans.
    Ahuja S; Ahuja P; Caffé AR; Ekstrom P; Abrahamson M; van Veen T
    Ophthalmic Res; 2006; 38(3):125-36. PubMed ID: 16374054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta.
    Kuźnik-Trocha K; Winsz-Szczotka K; Komosińska-Vassev K; Jura-Półtorak A; Kotulska-Kucharz A; Kucharz EJ; Kotyla P; Olczyk K
    Biomed Res Int; 2020; 2020():6416514. PubMed ID: 32382564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated glycosaminoglycans control the extracellular trafficking and the activity of the metalloprotease inhibitor TIMP-3.
    Troeberg L; Lazenbatt C; Anower-E-Khuda MF; Freeman C; Federov O; Habuchi H; Habuchi O; Kimata K; Nagase H
    Chem Biol; 2014 Oct; 21(10):1300-1309. PubMed ID: 25176127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of proteolytic-antiproteolytic enzymes and prooxidative-antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis.
    Winsz-Szczotka K; Komosińska-Vassev K; Kuźnik-Trocha K; Gruenpeter A; Lachór-Motyka I; Olczyk K
    Clin Biochem; 2014 Jun; 47(9):829-34. PubMed ID: 24495859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues.
    Schnabelrauch M; Scharnweber D; Schiller J
    Curr Med Chem; 2013; 20(20):2501-23. PubMed ID: 23521682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
    J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions.
    Robinson DE; Buttle DJ; Short RD; McArthur SL; Steele DA; Whittle JD
    Biomaterials; 2012 Feb; 33(4):1007-16. PubMed ID: 22079008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1.
    Carreca AP; Pravatà VM; Markham M; Bonelli S; Murphy G; Nagase H; Troeberg L; Scilabra SD
    Sci Rep; 2020 Jul; 10(1):12067. PubMed ID: 32694578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.